Skip to main content
. 2014 Feb 4;9(2):e87778. doi: 10.1371/journal.pone.0087778

Table 1. Demographic characteristics and experimental composite scores across participant groupsa.

Controls bvFTD AD Group effect bvFTD vs. Control AD vs. Control bvFTD vs. AD
N 35 22 32
Sex (M/F) 19/16 14/8 20/12 n.s. . . .
Mean age (years) 64.20 (5.38) 61.23 (7.45) 63.53 (6.98) n.s. . . .
Education (years) 12.79 (2.60) 11.33 (2.51) 12.41 (3.28) n.s. . . .
Disease duration (years) . 3.82 (2.44) 3.20 (2.09) . . . n.s.
FRS Rasch score b . −0.37 (1.02) 0.25 (0.96) . . . n.s.
CDR sum of boxes [18] b 0.32 (0.46) 7.08 (2.86) 5.05 (2.68) *** *** *** **
ACE-R [100] 95.00 (3.3) 76.00 (10.47) 67.84 (17.75) *** *** *** n.s.
CBI-R total frequency score [180] 3.77 (4.57) 67.36 (34.72) 40.33 (26.48) *** *** *** n.s.
CBI-R selected subscores:
Memory/Orientation [32] 1.50 (2.68) 16.18 (6.95) 16.00 (7.27) *** *** *** n.s.
Everyday skills [20] 0.17 (0.389) 7.09 (5.49) 7.25 (5.599) *** *** *** n.s.
Abnormal behaviour [24] 0.25 (0.45) 9.18 (6.74) 2.08 (2.31) *** *** n.s. **
Stereotypic/motor behaviours [16] 0.58 (0.79) 7 (5.33) 1.5 (2.15) ** *** n.s. **
Recall composite 99.56 (21.1) 37.86 (28.76) 20.55 (18.69) *** *** *** n.s.
DLPFC task composite 99.53 (18.88) 54.60 (26.03) 57.39 (21.73) *** *** *** n.s.
VMPFC task composite 99.81 (7.95) 69.26 (17.19) 82.88 (15.03) *** *** *** ***
a

Standard deviations in parentheses, maximum score for tests shown in brackets.

b

All patients had either FRS or CDR disease severity measures.

**

p<.01, ***p<.001, n.s. = non-significant.